cause of death
in antibiotics increases mortality by 8%
Abnormal blood cells which are prematurely released from the bone marrow into the blood stream may indicate blood cancers or other severe disorders.
These cells can only be detected using microscopic inspection.
The HemoScreen™ analysis method, very similar to the gold standard blood-smear, can accurately enumerate different abnormal cells at the primary care level, even before patients are symptomatic.
Heart failure occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. To adequately assess the risk of a given heart failure patient, there is a need for a combined-marker approach.
The “Early Heart Failure” HemoScreen™ diagnostic technology utilizes a unique combination of multiple pathophysiological pathway markers to provide immediate information on the patient’s risk status upon heart failure, at the point-of-care.